Related Experiment Videos
Biochemical abnormalities in cerebrotendinous xanthomatosis
G Salen1, S Shefer, V Berginer
1UMD-New Jersey Medical School, Newark.
Developmental Neuroscience
|January 1, 1991
Summary
Cerebrotendinous xanthomatosis (CTX) is a rare inherited lipid disorder. This review focuses on the liver
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Cerebrotendinous xanthomatosis (CTX) is a rare, autosomal recessive inherited disorder of lipid metabolism.
- Characterized by progressive neurological symptoms including dementia, ataxia, and neuropathy.
- Biochemical abnormalities are most pronounced in the liver, despite primary clinical manifestations in the nervous system.
Purpose of the Study:
- To review the pathogenesis of biochemical abnormalities in CTX.
- To discuss current and potential treatment strategies for CTX.
Main Methods:
- Literature review of pathogenesis and treatment of CTX.
- Analysis of biochemical pathways affected in CTX.
- Synthesis of clinical and research findings.
Main Results:
- CTX results from mutations in the CYP2U1 gene, affecting bile acid synthesis.
- Accumulation of cholestanol and cholesterol in various tissues, particularly the brain and tendons.
- Liver plays a central role in the expression of metabolic defects.
Conclusions:
- Understanding CTX pathogenesis is crucial for developing effective therapies.
- Treatment strategies aim to normalize bile acid metabolism and reduce lipid accumulation.
- Early diagnosis and intervention are key to managing CTX progression.